In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds. The results ...

Genentech's atezolizumab has been granted a fast review in the US for some cases of advanced non-small cell lung cancer. The US Food and Drug Administration has granted a Priority Review for the ...

This study is looking at using a blood sample to detect small pieces of DNA released into the blood by cancer cells. Read more about A study using a blood sample to diagnose cancer (PREVAILctDNA) A ...

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

NICE is unable to make a recommendation about the use in the NHS of atezolizumab (Tecentriq) for untreated advanced or recurrent non-small-cell lung cancer when platinum-doublet chemotherapy is ...

Roche has suffered a setback with its much-anticipated pairing of anti-TIGIT antibody tiragolumab and PD-L1 inhibitor Tecentriq in small cell lung cancer (SCLC), in a blow to its ambitions in ...